A 12-month interventional study demonstrates the beneficial effects of semaglutide, both oral and subcutaneous, on body weight, insulin resistance, liver function, lipid profile, and hepatic steatosis
We'll discuss the different types of GLP-1 agonists available and how they work
doi:10.1002/14651858.CD008650.pub2
AOM prescribing increased in December 2025 compared to September 2025 (+10.1%)
Evidence from the National Weight Control Registry, which tracks individuals who have maintained significant weight loss long-term, provides valuable insights into effective strategies, though these findings are observational
These ads can be appealing, intrusive, confusing or even misleading, and have sparked widespread concerns about inappropriate use and adverse events